Comparative Efficacy of Biologicals for Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review and Bayesian Network Meta‐Analysis

Clinical & Experimental Allergy 2026 Open access

Read full text
Authors: Wenjing Chen, Yihao Shao, Stephen R. Durham, Martín Penagos, Mei Jiang, Mianquan Zhang, Meng Xun
DOI: 10.1111/cea.70233
Cited by: 0
References: 7

Abstract

Summary Compared to placebo, Dupilumab and Stapokibart (CM310) demonstrate the most significant therapeutic efficacy in treating CRSwNP. All biologics demonstrated favourable safety profiles, with Dupilumab exhibiting the lowest risk of adverse events.

Fields of Study & Subjects

Sinusitis and nasal conditions Cystic Fibrosis Research Advances Antifungal resistance and susceptibility

Publication details

Journal / source
Clinical & Experimental Allergy
Volume
56
Issue
5
Pages
579–581
Publication date
13 February 2026
Language
EN